Figure 1.
Flow of participants through the enrollment and treatment.
Table 1.
Time periods of trial progression.
Table 2.
Pre-randomization characteristics of the 78 women with primary dysmenorrhoea.
Table 3.
Self-reported episode frequency (person-episodes) of symptoms described in traditional Chinese medicine during the pre-treatment (wash-out and baseline cycles) and treatment phases.
Figure 2.
Peak-pain change based on the GEE model.
Y-axis: Peak-Pain Score (cm) in the First Five Days of Menstruation. X-axis: Cycle (0 is the baseline cycle closest to the start of treatment, 1–4 are treatment).
Figure 3.
Distribution of peak-pain intensity throughout the trial.
Y-axis: Peak-Pain Score (cm) in the First Five Days of Menstruation. X-axis: Cycles within the phase. Phases of the entire trial.
Figure 4.
Distribution of overall-pain intensity throughout the trial.
Y-axis: Overall-Pain Score (cm) in the First Five Days of Menstruation. X-axis: Cycles within the phase. Phases of the entire trial.
Figure 5.
Peak-pain intensity distribution stratified by whether women had the 4th treatment cycle.
Y-axis: Peak-Pain Score (cm) in the First Five Days of Menstruation. X-axis: Cycles within the phase. Phases of the entire trial.
Table 4.
Percentage of women who did not feel pain after receiving the treatment.
Table 5.
Mean (standard deviation) haematological parameters at screening (the last wash-out cycle) and post-treatment (end of treatment) of the 76 women.